Stryker Japan Launches Innovative Tornier Perform Fracture Shoulder System

Introduction of Tornier Perform Fracture

Stryker Japan, headquartered in Shinjuku, Tokyo, is set to launch the innovative "Tornier Perform Fracture" artificial shoulder joint system in August 2026. This product represents the next step in the Tornier Perform series, which aims to address shoulder-related chronic conditions with the previously released "Tornier Perform Stem" system.

The "Tornier Perform Fracture" is specifically designed to manage proximal humeral fractures, a common ailment often arising from falls, particularly among the elderly. Conventional treatment methods, such as plates or screws, may not lead to satisfactory healing in certain cases due to deteriorated bone quality or the severity of the fractures. As such, a shoulder replacement with an artificial joint often becomes the preferred option.

Unique Features of the Tornier Perform Fracture

This latest system from Stryker is characterized by its focus on improving floor-to-ceiling motion through an innovative design. It incorporates a reverse shoulder joint structure that alters the connection between the scapula and the humerus head, which enhances the range of motion for patients. The product is equipped with proprietary 3D preoperative planning software that allows surgeons to simulate the range of motion before the operation, ultimately aiming to enrich patients' post-surgical quality of life (QOL).

Additionally, the Tornier Perform Fracture employs a porous titanium coating on its stems, facilitating better integration with new bone growth and reducing dependency on traditional bone cement, which has historically been used to strengthen fixation. This innovative approach promises more effective and reliable outcomes, as it minimizes the variables associated with cement application.

In situations requiring enhanced stability within the medullary cavity, supplementary fixation can be achieved using transverse screws, which are poised to become available in January 2027. The diameter and length of the stem can be tailored to meet the needs of a diverse patient demographic, especially those who are typically smaller in stature in the Japanese market.

Comprehensive Treatment Portfolio

With the introduction of the "Tornier Perform Fracture," Stryker Japan has completed its product lineup for treating fractures in the shoulder and humeral bone domain. This offers an extensive range of solutions, including the plate system "Pangea," the humeral intramedullary nail system "T2 Alpha Humerus," and the artificial shoulder joint system, all designed to cater to various patients' conditions, bone quality, and the specific surgical plans devised by medical professionals.

Stryker Japan's Commitment to Healthcare

Stryker Japan operates as a subsidiary of Stryker Corporation, based in Michigan, USA, and is recognized as a global leader in medical technology. The company collaborates with healthcare providers to enhance healthcare delivery. They offer innovative medical devices and services across numerous sectors, including surgical instruments, neurotechnology, and orthopedics. Annually, Stryker contributes to the well-being of over 150 million patients worldwide.

For further information, please visit www.stryker.com/jp.

Conclusion

Stryker Japan is committed to advancing medical technologies and improving patient outcomes. With the new "Tornier Perform Fracture" system, they aim to set new standards in fracture treatment for shoulder injuries, further solidifying their position in the orthopedic market and emphasizing their dedication to quality care and innovation.